![Pei Lan Chu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pei Lan Chu
Finansdirektör/CFO på
SYNERGY SCIENTECH CORP.
Profil
Pei Lan Chu is currently the Chief Financial Officer & Deputy General Manager at SYNergy ScienTech Corp.
Prior to this, he worked as the Investment Relations Officer at Tanvex BioPharma, Inc. from 2015 to 2019.
Before that, he was the Director-Biotech Section at President International Development Corp.
Mr. Chu holds an MBA from National Sun Yat-Sen University.
Aktiva positioner av Pei Lan Chu
| Företag | Position | Start |
|---|---|---|
| SYNERGY SCIENTECH CORP. | Finansdirektör/CFO | 2019-07-01 |
Tidigare kända positioner av Pei Lan Chu
| Företag | Position | Slut |
|---|---|---|
| TANVEX BIOPHARMA, INC. | Investor Relations Kontakt | - |
President International Development Corp.
 President International Development Corp. Financial ConglomeratesFinance manages investments and provides financial consulting services | Företagsledare/Principal | - |
Pei Lan Chus utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
25
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
National Sun Yat-Sen University
 National Sun Yat-Sen University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SYNergy ScienTech Corp.
 SYNergy ScienTech Corp. Electrical ProductsProducer Manufacturing Manufactures rechargeable lithium-ion and lithium-ion polymer batteries | Producer Manufacturing |
President International Development Corp.
President International Development Corp. Financial ConglomeratesFinance manages investments and provides financial consulting services | Finance |
Tanvex BioPharma, Inc.
 Tanvex BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures biosimilar medicines to treat neutropenia, breast cancer and metastatic colorectal cancer | Health Technology |
